Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: MRNA

Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin
Today, 9:42 AM
Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.

ACGN

Read More
2 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap
  • Trading Ideas

Alphabet To Rally Around 37%? Here Are 10 Other Analyst Forecasts For Wednesday

By Lisa Levin
Today, 9:42 AM
Morgan Stanley cut the price target for IBM (NYSE: IBM) from $152 to $148. Morgan Stanley analyst Erik Woodring downgraded the stock from Overweight to Equal-Weight. IBM shares fell 2.3% to $141.80 in pre-market trading.

EVER

Read More
4 minute read
  • Earnings
  • Economics
  • Federal Reserve
  • Futures
  • Markets
  • News
  • Pre-Market Outlook
  • Previews
  • Top Stories
  • Trading Ideas

US Stocks Flat Ahead Of Data Deluge — But Analyst Says Investors May Be In For A Surprise As Earnings Pessimism Overdone

By Shanthi Rexaline
Today, 9:42 AM
U.S. stocks may get off to a nervous start on Wednesday, as apprehensions concerning fourth-quarter earnings and the state of the economy continue to weigh down.

AA

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

Charles Schwab, Moderna And 3 Stocks To Watch Heading Into Wednesday

By Lisa Levin
Today, 9:42 AM
With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

AA

Read More
2 minute read
  • Earnings
  • Markets
  • News
  • Top Stories

Tesla, Amazon, Moderna, United Airlines, Goldman Sachs: Why These 5 Stocks Are Drawing Heavy Attention Today

By Bhavik Nair
Today, 9:42 AM
Major Wall Street indices closed mixed on Tuesday, with the Dow Jones falling over 1%, pressured by Goldman Sachs Group Inc (NYSE: GS) earnings.

AMZN

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People

By Vandana Singh
Today, 9:42 AM
The U.S.

BNTX

Read More
1 minute read
  • News

Overview Of Value Stocks In The Healthcare Sector

By Benzinga Insights
Today, 9:42 AM
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices…

ACRX

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Small Cap

Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot

By Vandana Singh
Today, 9:42 AM
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.

BNTX

Read More
2 minute read
  • Markets
  • Options

Looking At Moderna’s Recent Unusual Options Activity

By Benzinga Insights
Today, 9:42 AM
A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 20 strange trades.

MRNA

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

How Is The Market Feeling About Moderna?

By Benzinga Insights
Today, 9:42 AM
Moderna's (NASDAQ:MRNA) short percent of float has fallen 15.79% since its last report. The company recently reported that it has 14.04 million shares sold short, which is 4.96% of all regular shares that are available for trading.

MRNA

Posts navigation

Previous 1 … 3 4 5 … 136 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service